DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1, GPE, CGRP), Therapeutic Area (Nephrology, Gastroenterology, Genetic, CNS, Obesity, Diabetes), Formulation (Tablet, Capsule) - Global Forecast to 2030 USD 19.93 BN MARKET SIZE, 2030 OVERVIEW Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The global oral proteins & peptides market is projected to reach USD 19.93 billion by 2030 from USD 9.31 billion in 2025, at a CAGR of 16.4% during the forecast period
Whether for novel compounds or generics, such molecules will require user-friendly self-injection solutions developed by a device partner with proven expertise in producing devices for this emerging disease area
Symptomatic cholelithiasis prevails in 60.4% of patients with cholelithiasis
Vanilla protein powder helps make small servings more satisfying without adding bulk
Instead, the way they work and affect your metabolism may reduce your body's ability to absorb iron